Role of Pluronic block copolymers in modulation of heat shock protein 70 expression

International Journal of Hyperthermia

Volumn 27, Issue 7, 2011, Pages 672-681

  Perera, Reshani H ^a   Krupka, Tianyi M ^a   Wu, Hanping ^a   Traughber, Bryan ^a   Dremann, David ^a   Broome, Ann Marie ^a   Exner, Agata A ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Heat shock protein; Low grade hyperthermia; Pluronic

Indexed keywords

ADENOSINE TRIPHOSPHATE; HEAT SHOCK PROTEIN 70; POLOXAMER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL GROWTH; CELL VIABILITY; COLORECTAL CARCINOMA; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PROTEIN EXPRESSION; RAT; TEMPERATURE MEASUREMENT; TEMPERATURE SENSITIVITY;

ADENOCARCINOMA; ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; HSP70 HEAT-SHOCK PROTEINS; HYPERTHERMIA, INDUCED; POLOXAMER; RATS;

EID: 80054053876     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.3109/02656736.2011.608218     Document Type: Article

References (60)

1. Curley SA, Izzo F, Delrio P, Ellis LM, Granchi J, Vallone P, Fiore F, Pignata S, Daniele B, Cremona F. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: Results in 123 patients. Ann Surg 1999;230:1-8. (Pubitemid 30190357)
2. Zerbini A, Pilli M, Laccabue D, Pelosi G, Molinari A, Negri E, Cerioni S, Fagnoni F, Soliani P, Ferrari C, et al. Radiofrequency thermal ablation for hepatocellular carcinoma stimulates autologous NK-cell response. Gastroenterology 2010;138:1931-1942.
3. Poulou LS, Ziakas PD, Xila V, Vakrinos G, Malagari K, Syrigos KN, Thanos L. Percutaneous radiofrequency ablation for unresectable colorectal liver metastases: Time for shadows to disperse. Rev Recent Clin Trials 2009;4:140-146.
4. Lencioni R, Cioni D, Crocetti L, Franchini C, Pina CD, Lera J, Bartolozzi C. Early-stage hepatocellular carcinoma in patients with cirrhosis: Long-term results of percutaneous image-guided radiofrequency ablation. Radiology 2005;234:961-967. (Pubitemid 40250844)
5. Lees WR, Gillams A. Radiofrequency ablation: Other abdominal organs. Abdom Imaging 2005;30:451-455. (Pubitemid 41176123)
6. Varshney S, Sewkani A, Sharma S, Kapoor S, Naik S, Sharma A, Patel K. Radiofrequency ablation of unresectable pancreatic carcinoma: Feasibility, efficacy and safety. J Pancreas 2006;7:74-8. (Pubitemid 43103805)
7. McAchran SE, Lesani OA, Resnick MI. Radiofrequency ablation of renal tumors: Past, present, and future. Urology 2005;66:15-22. (Pubitemid 41356554)
8. Gervais DA, McGovern FJ, Arellano RS, McDougal W, Mueller PR. Radiofrequency ablation of renal cell carcinoma: Part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. Am J Roentgenol 2005;185:64-71.
9. Dupuy DE, DiPetrillo T, Gandhi S, Ready N, Ng T, Donat W, Mayo-Smith WW. Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer. Chest 2006;129:738-745.
10. Solbiati L, Goldberg SN, Ierace T, Livraghi T, Meloni F, Dellanoce M, Sironi S, Gazelle GS. Hepatic metastases: Percutaneous radio-frequency ablation with cooled-tip electrodes. Radiology 1997;205:367-373.
11. Solbiati L, Ierace T, Tonolini M, Osti V, Cova L. Radiofrequency thermal ablation of hepatic metastases. Eur J Ultrasound 2001;13:149-158. (Pubitemid 32463284)
12. Tateishi R, Shiina S, Teratani T, Obi S, Sato S, Koike Y, Fujishima T, Yoshida H, Kawabe T, Omata M. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005;103:1201-1209. (Pubitemid 40328091)
13. Calderwood SK, Ciocca DR. Heat shock proteins: Stress proteins with Janus-like properties in cancer. Int J Hyperthermia 2008;24:31-39. (Pubitemid 351167617)
14. Solazzo SA, Ahmed M, Schor-Bardach R, Yang W, Girnun GD, Rahmanuddin S, Levchenko T, Signoretti S, Spitz DR, Torchilin V, et al. Liposomal doxorubicin increases radiofrequency ablation-induced tumor destruction by increasing cellular oxidative and nitrative stress and accelerating apoptotic pathways. Radiology 2010;255:62-74.
15. Vanagas T, Gulbinas A, Pundzius J, Barauskas G. Radiofrequency ablation of liver tumors (I): Biological background. Medicina (Kaunas) 2010;46:13-17.
16. Li GC, Mak JY. Re-induction of Hsp70 synthesis: An assay for thermotolerance. 1988. Int J Hyperthermia 2009; 25:249-257.
17. 2+ is essential for multistep activation of the heat shock factor in permeabilized cells. Mol Cell Biol 1991;11:3365-3368.
18. Shpund S, Gershon D. Alterations in the chaperone activity of Hsp70 in aging organisms. Arch Gerontol Geriatr 1997;24: 125-131. (Pubitemid 27072987)
19. Creagh EM, Carmody RJ, Cotter TG. Heat shock protein 70 inhibits caspase-dependent and independent apoptosis in Jurkat T cells. Exp Cell Res 2000;257:58-66. (Pubitemid 30324644)
20. Mehlen P, Mehlen A, Godet J, Arrigo AP. Hsp27 as a switch between differentiation and apoptosis in murine embryonic stem cells. J Biol Chem 1997;272:31657-31665. (Pubitemid 28013312)
21. Horman S, Galand P, Mosselmans R, Legros N, Leclercq G, Mairesse N. Changes in the phosphorylation status of the 27 kDa heat shock protein (Hsp27) associated with the modulation of growth and/or differentiation in MCF-7 cells. Cell Prolif 1997;30:21-35. (Pubitemid 27374593)
22. Ghassemi M, Heydari AR, Richardson A. Induction of heat shock proteins in lymphocytes increases with mitogen stimulation. Immunol Lett 1991;30:333-337.
23. Yun JK, McCormick TS, Villabona C, Judware RR, Espinosa MB, Lapetina EG. Inflammatory mediators are perpetuated in macrophages resistant to apoptosis induced by hypoxia. Proc Natl Acad Sci USA 1997;94:13903-13908. (Pubitemid 28009682)
24. Karlseder J, Wissing D, Holzer G, Orel L, Sliutz G, Auer H, Jaattela M, Simon MM. Hsp70 overexpression mediates the escape of a doxorubicin-induced G2 cell cycle arrest. Biochem Biophys Res Commun 1996;220:153-159. (Pubitemid 26106815)
25. Ciocca DR, Fuqua SA, Lock-Lim S, Toft DO, Welch WJ, McGuire WL. Response of human breast cancer cells to heat shock and chemotherapeutic drugs. Cancer Res 1992; 52:3648-3654.
26. Krupka TM, Weinberg BD, Ziats NP, Haaga JR, Exner AA. Injectable polymer depot combined with radiofrequency ablation for treatment of experimental carcinoma in rat. Invest Radiol 2006;41:890-897. (Pubitemid 44747117)
27. Exner AA, Krupka TM, Scherrer K, Teets JM. Enhancement of carboplatin toxicity by Pluronic block copolymers. J Control Release 2005;106:188-197. (Pubitemid 41140094)
28. Krupka TM, Weinberg BD, Wu H, Ziats NP, Exner AA. Effect of intratumoral injection of carboplatin combined with pluronic P85 or L61 on experimental colorectal carcinoma in rats. Exp Biol Med (Maywood) 2007;232:950-957. (Pubitemid 47026802)
29. Alakhov V, Moskaleva E, Batrakova EV, Kabanov AV. Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer. Bioconjug Chem 1996;7:209-216.
30. Kabanov AV, Batrakova EV, Alakhov VY. Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release 2002;82:189-212. (Pubitemid 34880178)
31. Kabanov AV, Batrakova EV, Alakhov VY. An essential relationship between ATP depletion and chemosensitizing activity of Pluronic block copolymers. J Control Release 2003;91:75-83. (Pubitemid 37288878)
32. Batrakova E, Lee S, Li S, Venne A, Alakhov V, Kabanov A. Fundamental relationships between the composition of pluronic block copolymers and their hypersensitization effect in MDR cancer cells. Pharm Res 1999;16:1373-1379. (Pubitemid 29449373)
33. Batrakova EV, Li S, Vinogradov SV, Alakhov VY, Miller DW, Kabanov AV. Mechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: Contributions of energy depletion and membrane fluidization. J Pharmacol Exp Ther 2001;299:483-493. (Pubitemid 32979659)
34. Batrakova EV, Kabanov AV. Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J Control Release 2008; 130:98-106.
35. Weinberg BD, Krupka TM, Haaga JR, Exner AA. Combination of sensitizing pretreatment and radiofrequency tumor ablation: Evaluation in rat model. Radiology 2008; 246:796-803.
36. Chiappetta DA, Sosnik A. Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: Improved hydrosolubility, stability and bioavailability of drugs. Eur J Pharm Biopharm 2007;66:303-317. (Pubitemid 46756232)
37. Mirza AN, Fornage BD, Sneige N, Kuerer HM, Newman LA, Ames FC, Singletary SE. Radiofrequency ablation of solid tumors. Cancer J 2001;7:95-102.
38. Kuvshinoff BW, Ota DM. Radiofrequency ablation of liver tumors: Influence of technique and tumor size. Surgery 2002;132:605-611, discussion 11-12.
39. Bleicher RJ, Allegra DP, Nora DT, Wood TF, Foshag LJ, Bilchik AJ. Radiofrequency ablation in 447 complex unresectable liver tumors: Lessons learned. Ann Surg Oncol 2003;10:52-58.
40. Ahmed M, Lukyanov AN, Torchilin V, Tournier H, Schneider AN, Goldberg SN. Combined radiofrequency ablation and adjuvant liposomal chemotherapy: Effect of chemotherapeutic agent, nanoparticle size, and circulation time. J Vasc Interv Radiol 2005;16:1365-1371. (Pubitemid 41463995)
41. Ahmed M, Goldberg SN. Combination radiofrequency thermal ablation and adjuvant IV liposomal doxorubicin increases tissue coagulation and intratumoural drug accumulation. Int J Hyperthermia 2004;20:781-802. (Pubitemid 39496856)
42. Ahmed M, Monsky WE, Girnun G, Lukyanov A, D'Ippolito G, Kruskal JB, Stuart KE, Torchilin VP, Goldberg SN. Radiofrequency thermal ablation sharply increases intratumoral liposomal doxorubicin accumulation and tumor coagulation. Cancer Res 2003;63:6327-6333. (Pubitemid 37255180)
43. Ahmed M, Liu Z, Lukyanov AN, Signoretti S, Horkan C, Monsky WL, Torchilin VP, Goldberg SN. Combination radiofrequency ablation with intratumoral liposomal doxorubicin: Effect on drug accumulation and coagulation in multiple tissues and tumor types in animals. Radiology 2005;235:469-477. (Pubitemid 40571084)
44. Goldberg SN, Girnan GD, Lukyanov AN, Ahmed M, Monsky WL, Gazelle GS, Huertas JC, Stuart KE, Jacobs T, Torchillin VP, et al. Percutaneous tumor ablation: Increased necrosis with combined radio-frequency ablation and intravenous liposomal doxorubicin in a rat breast tumor model. Radiology 2002;222:797-804. (Pubitemid 34215233)
45. Haaga JR, Exner AA, Wang Y, Stowe NT, Tarcha PJ. Combined tumor therapy by using radiofrequency ablation and 5-FU-laden polymer implants: Evaluation in rats and rabbits. Radiology 2005;237:911-918. (Pubitemid 41636381)
46. Curley SA. Radiofrequency ablation of malignant liver tumors. Oncologist 2001;6:14-23. (Pubitemid 32155812)
47. Hoffman AL, Wu SS, Obaid AK, French SW, Lois J, McMonigle M, Ramos HC, Sher LS, Lopez RR. Histologic evaluation and treatment outcome after sequential radiofrequency ablation and hepatic resection for primary and metastatic tumors. Am Surg 2002;68:1038-1043. (Pubitemid 44943156)
48. Liu GJ, Moriyasu F, Hirokawa T, Rexiati M, Yamada M, Imai Y. Expression of heat shock protein 70 in rabbit liver after contrast-enhanced ultrasound and radiofrequency ablation. Ultrasound Med Biol 2010;36:78-85.
49. Yang WL, Nair DG, Makizumi R, Gallos G, Ye X, Sharma RR, Ravikumar TS. Heat shock protein 70 is induced in mouse human colon tumor xenografts after sublethal radiofrequency ablation. Ann Surg Oncol 2004;11: 399-406. (Pubitemid 40486750)
50. Krupka TM, Dremann D, Exner AA. Time and dose dependence of Pluronic bioactivity in hyperthermia-induced tumor cell death. Exp Biol Med (Maywood) 2009;234:95-104.
51. Krupka TM EA. Structural parameters govering activity of Pluronic triblock copolymers in hyperthermia cancer therapy. Int J Hyperthermia 2011, In press.
52. Rapoport N, Marin AP, Timoshin AA. Effect of a polymeric surfactant on electron transport in HL-60 cells. Arch Biochem Biophys 2000;384:100-108.
53. Batrakova EV, Li S, Alakhov VY, Miller DW, Kabanov AV. Optimal structure requirements for Pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells. J Pharmacol Exp Ther 2003;304:845-854. (Pubitemid 36152365)
54. Rapoport N, Pitt WG, Sun H, Nelson JL. Drug delivery in polymeric micelles: From in vitro to in vivo. J Control Release 2003;91:85-95. (Pubitemid 37288879)
55. Hahn GM, Strande DP. Cytotoxic effects of hyperthermia and adriamycin on Chinese hamster cells. J Natl Cancer Inst 1976;57:1063-1067.
56. Shivers RR, Wijsman JA. Blood-brain barrier permeability during hyperthermia. Prog Brain Res 1998;115:413-424. (Pubitemid 28264332)
57. Helbig D, Bodendorf M, Anderegg U, Simon J, Paasch U. A human skin explant model to study molecular changes in response to fractional photothermolysis: Spatio-temporal expression of HSP70. Med Laser Appl 2010;25:173-180.
58. Charveron M, Calvo M, Gall Y. Cell stress and implications of the heat-shock response in skin. Cell Biol Toxicol 1995;11:161-165.
59. Laplante AF, Moulin V, Auger FA, Landry J, Li H, Morrow G, Tanguay RM, Germain L. Expression of heat shock proteins in mouse skin during wound healing. J Histochem Cytochem 1998;46:1291-1301. (Pubitemid 28487749)
60. Sahin E, Sahin M, Sanlioglu AD, Gumuslu S. KNK437, a benzylidene lactam compound, sensitises prostate cancer cells to the apoptotic effect of hyperthermia. Int J Hyperthermia 2011;27:63-73.